The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
NCT01608724
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2165
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Interventions
DRUG:
Saxagliptin
Sponsor
AstraZeneca